Taken together, these results highlight the potential of EGFL8 as a biomarker for various cancers, including ovarian, gastric, colorectal, and hepatocellular carcinomas, as well as its biological functions in different cell types and tissues such as ovarian stromal cells, vascular endothelial cells, and smooth muscle cells. This evidence concerns the gene EGFL8 and hepatocellular carcinoma.